(Q28474806)

18

0 references

Francesca Incardona

6

0 references

Anne-Mieke Vandamme

17

0 references

Carlo Torti

16

0 references

Eugenia Quiros-Roldan

13

0 references

Matthias Assel

3

0 references

Viktor Müller

Viktor Müller

9

0 references

Massimiliano Fabbiani

Massimiliano Fabbiani

5

0 references

Andrea De Luca

Andrea De Luca

4

0 references

Mattia Prosperi

12

Mattia Prosperi

0 references

Pieter Libin

7

Pieter Libin

0 references

author name string

Dineke Frentz

1

0 references

Charles A B Boucher

2

0 references

Nino Manca

8

0 references

Breanndán O Nualláin

10

0 references

Roger Paredes

11

0 references

Lidia Ruiz

14

0 references

Peter M A Sloot

15

0 references

David A M C van de Vijver

Creative Commons Attribution 4.0 International

20

0 references

language of work or name

English

0 references

publication date

9 July 2010

0 references

published in

PLOS One

0 references

volume

5

0 references

issue

7

0 references

page(s)

e11505

0 references

copyright license

start time

9 July 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Predictive value of HIV-1 genotypic resistance test interpretation algorithms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

Update of the Drug Resistance Mutations in HIV-1.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

Web resources for HIV type 1 genotypic-resistance test interpretation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

Clinically validated genotype analysis: guiding principles and statistical concerns.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

Impact of drug resistance mutations on virologic response to salvage therapy

2 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011505

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011505

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011505

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011505

HIV decision support: from molecule to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011505

Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011505

The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0011505

Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

Multi-science decision support for HIV drug resistance treatment.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

The development of artificial neural networks to predict virological response to combination HIV therapy.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901338

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20634893